Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 1
1994 1
1995 1
1998 1
1999 1
2000 2
2001 2
2002 5
2003 7
2004 5
2005 7
2006 5
2007 7
2008 9
2009 5
2010 7
2011 7
2012 6
2013 5
2014 6
2015 5
2016 3
2017 6
2018 7
2019 2
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21774762

106 results
Results by year
Filters applied: . Clear all
Page 1
Sarcolemmal KATP channel modulators and cardiac arrhythmias.
Baczkó I, Husti Z, Lang V, Leprán I, Light PE. Baczkó I, et al. Curr Med Chem. 2011;18(24):3640-61. doi: 10.2174/092986711796642472. Curr Med Chem. 2011. PMID: 21774762 Review.
Intracellular signalling mechanism responsible for modulation of sarcolemmal ATP-sensitive potassium channels by nitric oxide in ventricular cardiomyocytes.
Zhang DM, Chai Y, Erickson JR, Brown JH, Bers DM, Lin YF. Zhang DM, et al. J Physiol. 2014 Mar 1;592(5):971-90. doi: 10.1113/jphysiol.2013.264697. Epub 2013 Nov 25. J Physiol. 2014. PMID: 24277866 Free PMC article.
Both mitochondrial KATP channel opening and sarcolemmal KATP channel blockage confer protection against ischemia/reperfusion-induced arrhythmia in anesthetized male rats.
Gonca E, Bozdogan O. Gonca E, et al. J Cardiovasc Pharmacol Ther. 2010 Dec;15(4):403-11. doi: 10.1177/1074248410372925. Epub 2010 Aug 5. J Cardiovasc Pharmacol Ther. 2010. PMID: 20693159
ATP-sensitive potassium channel modulators and cardiac arrhythmias: an update.
Muntean DM, Kiss L, Jost N, Baczko I. Muntean DM, et al. Curr Pharm Des. 2015;21(8):1091-102. doi: 10.2174/1381612820666141029102800. Curr Pharm Des. 2015. PMID: 25354183 Review.
The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy.
Billman GE. Billman GE. Pharmacol Ther. 2008 Oct;120(1):54-70. doi: 10.1016/j.pharmthera.2008.07.004. Epub 2008 Jul 26. Pharmacol Ther. 2008. PMID: 18708091 Review.
Role of sarcolemmal ATP-sensitive potassium channel in oxidative stress-induced apoptosis: mitochondrial connection.
Marinovic J, Ljubkovic M, Stadnicka A, Bosnjak ZJ, Bienengraeber M. Marinovic J, et al. Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1317-25. doi: 10.1152/ajpheart.00840.2007. Epub 2008 Jan 11. Am J Physiol Heart Circ Physiol. 2008. PMID: 18192220 Free article.
Role of ATP-sensitive K+ channels in cardiac arrhythmias.
Nakaya H. Nakaya H. J Cardiovasc Pharmacol Ther. 2014 May;19(3):237-43. doi: 10.1177/1074248413515078. Epub 2013 Dec 23. J Cardiovasc Pharmacol Ther. 2014. PMID: 24367007 Review.
PKC-permitted elevation of sarcolemmal KATP concentration may explain female-specific resistance to myocardial infarction.
Edwards AG, Rees ML, Gioscia RA, Zachman DK, Lynch JM, Browder JC, Chicco AJ, Moore RL. Edwards AG, et al. J Physiol. 2009 Dec 1;587(Pt 23):5723-37. doi: 10.1113/jphysiol.2009.181040. Epub 2009 Oct 5. J Physiol. 2009. PMID: 19805744 Free PMC article.
Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection.
Sato T, Costa AD, Saito T, Ogura T, Ishida H, Garlid KD, Nakaya H. Sato T, et al. J Pharmacol Exp Ther. 2006 Jan;316(1):182-8. doi: 10.1124/jpet.105.094029. Epub 2005 Sep 20. J Pharmacol Exp Ther. 2006. PMID: 16174795
Effects of the blockade of cardiac sarcolemmal ATP-sensitive potassium channels on arrhythmias and coronary flow in ischemia-reperfusion model in isolated rat hearts.
Gok S, Vural K, Sekuri C, Onur R, Tezcan A, Izanli A. Gok S, et al. Vascul Pharmacol. 2006 Apr;44(4):197-205. doi: 10.1016/j.vph.2005.11.006. Epub 2006 Feb 21. Vascul Pharmacol. 2006. PMID: 16495160
106 results
Jump to page